Richard A. Larson to Oligonucleotides, Antisense
This is a "connection" page, showing publications Richard A. Larson has written about Oligonucleotides, Antisense.
Connection Strength
0.030
-
Phase I study of oblimersen sodium, an antisense to Bcl-2, in untreated older patients with acute myeloid leukemia: pharmacokinetics, pharmacodynamics, and clinical activity. J Clin Oncol. 2005 May 20; 23(15):3404-11.
Score: 0.016
-
G3139, a BCL-2 antisense oligo-nucleotide, in AML. Ann Hematol. 2004; 83 Suppl 1:S93-4.
Score: 0.014